ClinicalTrials.Veeva
Menu

Find clinical trials for Melanoma in Portland, OR

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Renal Cell Carcinoma
Lung Cancer
Squamous Cell Carcinoma

Melanoma trials near Portland, OR, USA:

Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma

The purpose of this study is to evaluate the efficacy of lenvatinib and pembrolizumab to treat metastatic uveal melanoma....

Enrolling
Melanoma, Uveal
Drug: Lenvatinib
Drug: Pembrolizumab

Phase 2

Providence Health & Services
Providence Health & Services

Portland, Oregon, United States

Prospective, interventional multicenter study evaluating adoptive cell therapy (ACT) via infusion of LN-144 (autologous TIL) followed by interleukin...

Active, not recruiting
Metastatic Melanoma
Biological: Lifileucel

Phase 2

Iovance Biotherapeutics

Portland, Oregon, United States and 56 other locations

To evaluate the overall survival of HLA-A\*0201 positive adult patients with previously untreated advanced UM receiving IMCgp100 compared to Investig...

Active, not recruiting
Uveal Melanoma
Biological: IMCgp100
Biological: Pembrolizumab

Phase 2

Immunocore
Immunocore

Portland, Oregon, United States and 55 other locations

study is to determine the objective response of GB1211 and pembrolizumab versus pembrolizumab and placebo in patients with advance metastatic melanoma...

Enrolling
Metastatic Melanoma
Head and Neck Squamous Cell Carcinoma
Drug: GB1211
Drug: Placebo

Phase 2

Providence Health & Services
Providence Health & Services

Portland, Oregon, United States

The purpose of this study is compare the response rates in patients with metastatic melanoma treated with high-dose IL-2 to patients treated...

Active, not recruiting
Metastatic Melanoma
Other: Radiation therapy and high-dose IL-2
Drug: High-dose IL-2

Phase 2

Providence Health & Services
Providence Health & Services

Portland, Oregon, United States

and feasibility of a humanized OX40 agonist, MEDI0562, in the pre-operative setting for patients with head and neck squamous cell carcinoma or melanoma...

Active, not recruiting
Melanoma
Carcinoma, Squamous Cell
Drug: MEDI0562

Phase 1

Providence Health & Services
Providence Health & Services

Portland, Oregon, United States

PV-10 in combination with immune checkpoint inhibition. Metastatic melanoma patients (Stage IV or Stage III unresectable, in-transit or sate...

Active, not recruiting
Melanoma
Drug: Pembrolizumab
Drug: PV-10

Phase 1, Phase 2

Provectus Biopharmaceuticals

Portland, Oregon, United States and 4 other locations

This is a single arm phase II clinical trial of Ipilimumab and Nivolumab in patients with resected mucosal melanoma. Ipilimumab (1 mg/kg) an...

Active, not recruiting
Mucosal Melanoma
Drug: Nivolumab
Drug: Ipilimumab

Phase 2

Robert R. McWilliams, MD

Portland, Oregon, United States and 6 other locations

and pediatric participants after complete resection of Stage IIB/C melanoma with no evidence of disease (NED) who are at high risk for recur...

Active, not recruiting
Melanoma
Other: Placebo
Biological: Nivolumab

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Portland, Oregon, United States and 128 other locations

and pembrolizumab improves recurrence free survival (RFS) compared to pembrolizumab alone in participants with complete resection of cutaneous melanoma...

Enrolling
Melanoma
Drug: mRNA-4157
Biological: Pembrolizumab

Phase 2

Moderna
Moderna

Portland, Oregon, United States and 20 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems